Диссертация (1174297), страница 20
Текст из файла (страница 20)
I. The electrophoreticmigration of the alpha hemolytic, dermonecrotic, lethal, and leucocidal activitiesof crude toxin./ S. Kumar, R.K. Lindorfer // J Exp Med. – 1962. – 1. – 115. – P.1095-106.107. Lack, G. Avon longitudinal study of parents and children study team. Factorsassociated with the development of peanut allergy in childhood. / G. Lack, D.Fox, K. Northstone, J. Golding // N Eng J Med.
– 2003. – 348. – P. 977–985.108. Lansdown, A.B. Silver in health care: antimicrobial effects and safety in use. /A.B. Lansdown // Curr Prob Dermatol. – 2006. – 33. – P. 17—34.109. Laouini, D. Epicutaneous sensitization with superantigen induces allergic skininflammation. / D. Laouini, S. Kawamoto, A.
Yalcindag, P. Bryce, E. Mizoguchi,H. Oettgen, R.S. Geha // J. Allergy Clin. Immunol. – 2003. –112. – P. 981–987.110. Le, N. A. Regulation of serine protease inhibitor Kazal type-5 (SPINK5) geneexpression in the keratinocytes. / N.A. Le, M. Katsuyama, M. Demura, H.124Tanii, H. Katsuyama, K. Saijoh // Environ Health Prev Med. – 2014.
– 19(4). – P.307-13. doi: 10.1007/s12199-014-0393-7. Epub 2014 Jun 4.111. Leitch, C.S. Filaggrin-null mutations are associated with increased maturationmarkers on Langerhans cells. / C.S. Leitch, E. Natafji, C. Yu, S. Abdul-Ghaffar,N. Madarasingha, Z.C. Venables, R. Chu, P.M. Fitch, A.J. Muinonen-Martin,L.E. Campbell, W.H. McLean, J. Schwarze, S.E. Howie, R.B.
Weller// J AllergyClin Immunol. – 2016. – 138. – P. 482-90. e7.112. Leung, D.Y. Bacterial superantigens induce T cell expression of the skinselective homing receptor, the cutaneous lymphocyte-associated antigen, viastimulation of interleukin 12 production. / D.Y. Leung, M. Gately, A. Trumble,B. Ferguson-Darnell, P.M. Schlievert, L.J.
Picker // J. Exp. Med. – 1995. – 181. –P. 747–753.113. Leung, D.Y. Deciphering the complexities of atopic dermatitis: shiftingparadigms in treatment approaches. / D.Y. Leung, E. Guttman-Yassky // Clin RevAllergy Immunol. – 2014. – 134. – 4. – P. 769-779.114. Leung, D.Y. Effects of pimecrolimus cream 1% in the treatment of patients withatopic dermatitis who demonstrate a clinical insensitivity to topicalcorticosteroids: a randomized, multicenter vehicle-controlled trial.
/ D.Y. Leung,J.M. Hanifin, D.M. Pariser, K.A. Barber, R.G. Langley, P.M. Schlievert, B.Abrams, T. Hultsch // Br. J. Dermatol. – 2009. – 161. – P. 435– 443.115. Leung, D.Y. Presence of IgE antibodies to staphylococcal exotoxins on the skinof patients with atopic dermatitis. Evidence for a new group of allergens. / D.Y.Leung, R. Harbeck, P. Bina, R.F. Reiser, E. Yang, D.A. Norris, J.M.
Hanifin,H.A. Sampson // J. Clin. Invest. – 1993. – 92. P. 1374 –1380.116. Leyden, J.J. Staphylococcus aureus in the lesions of atopic dermatitis. / J.J.Leyden, R.R. Marples, A.M. Kligman // Br J Dermatol. – 1974. – 90. – P. 525–530.117. Lindsay, J.A. Microarrays reveal that each of the ten dominant lineages ofStaphylococcus aureus has a unique combination of surface-associated andregulatory genes. / J.A. Lindsay, C.E. Moore, N.P.
Day, S.J. Peacock, A.A.125Witney, R.A. Stabler, S.E. Husain, P.D. Butcher, J. Hinds. // J. Bacteriol. – 2006.– 188. – P. 669–676.118. Lindsay, J.A. Understanding the rise of the superbug: investigation of theevolution and genomic variation of Staphylococcus aureus. / J.A.
Lindsay, M.T.Holden // Funct Integr Genomics. – 2006. – 6. – P. 186–201.119. Los, F.C. Role of pore-forming toxins in bacterial infectious diseases. / F.C.Los, T.M. Randis, R.V. Aroian, A.J. Ratner// Microbiol Mol Biol Rev. – 2013. –77(2). – P.173-207. doi: 10.1128/MMBR.00052-12.120. Lyons, J. J. Atopic dermatitis in children: clinical features, pathophysiology,and treatment. / J.J. Lyons, J.D. Milner, K.D.
Stone // Immunol Allergy ClinNorth Am. – 2015. – 35(1). – P.161-83. doi: 10.1016/j.iac.2014.09.008. Epub2014 Nov 21.121. Matsui, T. SASPase regulates stratum corneum hydration through profilaggrin-tofilaggrin processing. / T. Matsui, K. Miyamoto, A. Kubo, H. Kawasaki, T.Ebihara, K. Hata, S.
Tanahashi, S. Ichinose, I. Imoto, J. Inazawa, J. Kudoh, M.Amagai // EMBO Mol Med. – 2011. – 3. – P. 320-33.122. Melehani, J.H. Staphylococcus aureus Leukocidin A/B (LukAB) Kills HumanMonocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular. /J.H. Melehani, D.B. James, A.L. DuMont, V.J. Torres , J.A. Duncan // PLoSPathog. – 2015. – Jun 12;11(6):e1004970. doi: 10.1371/journal.ppat.1004970.eCollection 2015 Jun.123. Miajlovic, H. Effect of filaggrin breakdown products on growth of and proteinexpression by Staphylococcus aureus. / H. Miajlovic, P.G. Fallon, A.D.
Irvine,T.J. Foster // J. Allergy Clin. Immunol. – 2010. – 126. – P. 1184 –1190.124. Monecke, S. High diversity of Panton-Valentine leukocidin-positive, methicillinsusceptible isolates of Staphylococcus aureus and implications for the evolutionof community-associated methicillin-resistant S. aureus. / S.
Monecke, P.Slickers, M.J. Ellington, A.M. Kearns, R. Ehricht. // Clin Microbiol Infect. –2007. – 13(12). – P.1157-64. Epub 2007 Oct 19.126125. Moon, B.Y. Phage-mediated horizontal transfer of a Staphylococcusaureus virulence-associated genomic island/ B.Y. Moon, J.Y. Park, S.Y. Hwang,D.A. Robinson, J.C. Thomas, J.R. Fitzgerald, Y.H.
Park, K.S. Seo. //Sci Rep.– 2015. – 5: 9784. Published online 2015 Apr 20. doi: 10.1038/srep09784126. Morar, N. The genetics of atopic dermatitis. / N. Morar, S.A. Willis-Owen, M.F.Moffatt, W.O. Cookson // J Allergy Clin Immunol. – 2006. – 118. – P. 24-34.127. Nada, H. A. Skin colonization by superantigen-producing Staphylococcus aureusin Egyptian patients with atopic dermatitis and its relation to disease severity andserum interleukin-4 level. / H.A. Nada, N.I. Gomaa, A. Elakhras, R. Wasfy, R.A.Baker // Int J Infect Dis.
– 2012. – 16(1). – P. 29-33. doi:10.1016/j.ijid.2011.09.014. Epub 2011 Oct 30.128. Naik, S. Compartmentalized control of skin immunity by resident commensals. /S. Naik, N. Bouladoux, C. Wilhelm, M.J. Molloy // Science. – 2012. – 6098. – P.1115–1119.129. Nelson, K.E. A catalog of reference genomes from the human microbiome/ K.E.Nelson, G.M. Weinstock, S.K. Highlander, K.C. Worley, H.H. Creasy, J.R.Wortman, D.B. Rusch, M. Mitreva, E. Sodergren, A.T. Chinwalla,M. Feldgarden,D. Gevers, B.J. Haas, R. Madupu, D.V.Ward, B.W. Birren, R.A. Gibbs, B.Methe, J.F.
Petrosino, R.L. Strausberg, G.G. Sutton, O.R. White, R.K. Wilson, S.Durkin, M.G. Giglio, S. Gujja, C. Howarth, C.D. Kodira, N. Kyrpides, et al //Science. – 2010. – 328. P. 994–999.130. Neuber, K. Effects of Staphylococcus aureus cell wall products (teichoic acid,peptidoglycan) and enterotoxin B on immunoglobulin (IgE, IgA, IgG) synthesisand CD23 expression in patients with atopic dermatitis. / K. Neuber, W.
König //Immunology. – 1992. – 75(1). – P. 23-8.131. Niebuhr, M. Antibiotic treatment of cutaneous infections with Staphylococcusaureus in patients with atopic dermatitis: current antimicrobial resistances andsusceptibilities. / M. Niebuhr, U. Mai, A. Kapp // Exp Dermatol. – 2008. –17(11). – P.
953–957.127132. Nishifuji, K. Staphylococcal exfoliative toxins: «molecular scissors» of bacteriathat attack the cutaneous defense barrier in mammals. / K. Nishifuji, M. Sugai, M.Amagai // J Dermatol Sci. – 2008. – 49. – P. 21–31.133. Noronha, C. Local burn treatment - topical antimicrobial agents. / C. Noronha, A.Almeida // Annals of Burns and Fire Disasters. – 2000. – 13(4). – P. 236.134. Novak, N. Immunoglobulin E-bearing antigen presenting cells in atopicdermatitis. / N. Novak, T. Bieber, S.
Kraft // Curr Allergy Asthma Rep. – 2004. –4. – P. 263-269.135. Novak, N. Unraveling the mission of the FceRI on antigenpresenting cells. / N.Novak, S. Kraft, T. Bieber // J Allergy Clin Immunol. – 2003. – 3. – P. 38-44.136. Ong P.Y. Endogenous antimicrobial peptides and skin infections in atopicdermatitis. / P.Y Ong, T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T.Ganz, R.L. Gallo, D.Y. Leung // N. Engl. J.
Med. – 2002. – 347. – P. 1151–1160.137. Ono, H.K. Identification and Characterization of Two Novel StaphylococcalEnterotoxins, Types S and T. / H.K. Ono, K. Omoe, K.I. Imanishi, Y. Iwakabe,D.L. Hu, H. Kato, N. Saito, A. Nakane, T. Uchiyama, K. Shinagawa // Infect.Immun. – 2008. – 76. – P. 4999–5005.138. Oranje, A.P. Evidence — based pharmacological treatment of atopic dermatitis:an expert opinion and new expectations/ A.P. Oranje // Indian J Dermatol. –2014.
– 59(2). – P. 140–142.139. Otto, M. MRSA virulence and spread. /M. Otto// Cellular microbiology. – 2012.–14(10). – P. 1513-1521. doi:10.1111/j.1462-5822.2012.01832.x.140. Ou, L.S. T regulatory cells in atopic dermatitis and subversion of their activity bysuperantigens. / L.S. Ou, E. Goleva, C. Hall, D.Y. Leung // J. Allergy Clin.Immunol. – 2004. – 113. – P. 756 –763.141. Paddle-Ledinek, J.
E. Effect of different wound dressings on cell viability andproliferation. / J.E. Paddle-Ledinek, Z. Nasa, H.J. Cleland // Plast Reconstr Surg.– 2006. – 117. – P. 110-118.142. Palmer, C. N. Common loss-of-function variants of the epidermal barrier proteinfilaggrin are a major predisposing factor for atopic dermatitis. / C.N.128Palmer, A.D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, S.P. Lee, D.R.Goudie, A. Sandilands, L.E. Campbell, F.J. Smith, G.M. O'Regan, R.M.Watson, J.E.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
